Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Profit After Tax (2022 - 2025)

Historic Profit After Tax for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$7.7 million.

  • CervoMed's Profit After Tax fell 6254.49% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.6 million, marking a year-over-year decrease of 11415.09%. This contributed to the annual value of -$16.3 million for FY2024, which is 65007.59% down from last year.
  • As of Q3 2025, CervoMed's Profit After Tax stood at -$7.7 million, which was down 6254.49% from -$6.3 million recorded in Q2 2025.
  • Over the past 5 years, CervoMed's Profit After Tax peaked at $2.2 million during Q3 2023, and registered a low of -$7.7 million during Q3 2025.
  • In the last 4 years, CervoMed's Profit After Tax had a median value of -$2.4 million in 2023 and averaged -$3.1 million.
  • As far as peak fluctuations go, CervoMed's Profit After Tax surged by 34363.31% in 2023, and later plummeted by 37055.32% in 2024.
  • Quarter analysis of 4 years shows CervoMed's Profit After Tax stood at -$1.5 million in 2022, then crashed by 54.67% to -$2.4 million in 2023, then tumbled by 183.86% to -$6.7 million in 2024, then decreased by 15.22% to -$7.7 million in 2025.
  • Its last three reported values are -$7.7 million in Q3 2025, -$6.3 million for Q2 2025, and -$4.9 million during Q1 2025.